{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T21:28:56Z","timestamp":1769462936992,"version":"3.49.0"},"reference-count":104,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T00:00:00Z","timestamp":1769212800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Children"],"abstract":"<jats:p>Background\/Objectives: Diencephalic syndrome (DS) is an uncommon pediatric disorder presenting with severe failure to thrive despite adequate caloric intake and preserved linear growth. First characterized by Russell, this condition predominantly affects infants under 12 months and remains diagnostically challenging. Methods: We performed a comprehensive literature review examining clinical presentation, underlying pathophysiology, associated pathology, diagnostic approaches, and long-term outcomes of DS. Results: DS typically manifests in the first year of life with profound cachexia, normal or increased appetite, preserved height velocity, and characteristic features including hyperactivity, euphorism, and visual pathway involvement. Low-grade gliomas of the hypothalamic\u2013chiasmatic region, particularly pilocytic astrocytomas, represent the predominant underlying pathology. The pathophysiological mechanisms remain incompletely understood but likely involve complex dysregulation of hypothalamic energy homeostasis. While overall survival exceeds 90% at five years, most patients experience significant long-term morbidity including visual impairment, multiple endocrine deficiencies, and hypothalamic obesity. Diagnostic delays averaging 11 months contribute to irreversible complications. Conclusions: Early recognition of DS is essential to prevent permanent visual loss and optimize outcomes. Multidisciplinary management incorporating chemotherapy as first-line treatment for underlying gliomas has improved survival while reducing radiation-associated toxicities. However, survivors face substantial lifelong sequelae requiring comprehensive monitoring and intervention. Future research should focus on elucidating precise pathophysiological mechanisms, developing targeted molecular therapies, and improving management of hypothalamic obesity and other late effects.<\/jats:p>","DOI":"10.3390\/children13020165","type":"journal-article","created":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T10:24:36Z","timestamp":1769423076000},"page":"165","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Diencephalic Syndrome: Clinical Features, Pathophysiology, and Long-Term Outcomes"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6052-3511","authenticated-orcid":false,"given":"Antonio","family":"Ruggiero","sequence":"first","affiliation":[{"name":"Pediatric Oncology Unit, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Rome, Italy"},{"name":"Department of Woman and Child Health and Public Health, Universit\u00e0 Cattolica del Sacro Cuore, 00168 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Palma","family":"Maurizi","sequence":"additional","affiliation":[{"name":"Pediatric Oncology Unit, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Rome, Italy"},{"name":"Department of Woman and Child Health and Public Health, Universit\u00e0 Cattolica del Sacro Cuore, 00168 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Romano","sequence":"additional","affiliation":[{"name":"Pediatric Oncology Unit, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Fuccillo","sequence":"additional","affiliation":[{"name":"Pediatric Oncology Unit, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7038-3519","authenticated-orcid":false,"given":"Dario","family":"Talloa","sequence":"additional","affiliation":[{"name":"Pediatric Oncology Unit, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Mastrangelo","sequence":"additional","affiliation":[{"name":"Pediatric Oncology Unit, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Rome, Italy"},{"name":"Department of Woman and Child Health and Public Health, Universit\u00e0 Cattolica del Sacro Cuore, 00168 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9053-8765","authenticated-orcid":false,"given":"Giorgio","family":"Attin\u00e0","sequence":"additional","affiliation":[{"name":"Pediatric Oncology Unit, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,1,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"De Martino, L., Picariello, S., Triarico, S., Improda, N., Spennato, P., Capozza, M.A., Grandone, A., Santoro, C., Cioffi, D., and Attin\u00e0, G. (2022). Diencephalic syndrome due to optic pathway gliomas in pediatric patients: An Italian multicenter study. Diagnostics, 12.","DOI":"10.3390\/diagnostics12030664"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1136\/adc.47.253.338","article-title":"Diencephalic syndrome of infantile emaciation: Analysis of literature and report of further 3 cases","volume":"47","author":"Addy","year":"1972","journal-title":"Arch. Dis. Child."},{"key":"ref_3","first-page":"274","article-title":"A diencephalic syndrome of emaciation in infancy and childhood","volume":"26","author":"Russell","year":"1951","journal-title":"Arch Dis Child."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3345\/kjp.2015.58.1.28","article-title":"Diencephalic syndrome: A frequently neglected cause of failure to thrive in infants","volume":"58","author":"Kim","year":"2015","journal-title":"Korean J. Pediatr."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"van Roessel, I.M., Schouten-van Meeteren, A.Y.N., Meijer, L., Hoving, E.W., Bakker, B., and van Santen, H.M. (2022). Transition From Diencephalic Syndrome to Hypothalamic Obesity in Children With Suprasellar Low Grade Glioma: A Case Series. Front. Endocrinol., 13.","DOI":"10.3389\/fendo.2022.846124"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S1388-2457(03)00282-7","article-title":"A fast visual evoked potential method for functional assessment and follow-up of childhood optic gliomas","volume":"115","author":"Trisciuzzi","year":"2004","journal-title":"Clin. Neurophysiol."},{"key":"ref_7","first-page":"1499","article-title":"Diencephalic syndrome: Clinical features and imaging findings","volume":"18","author":"Poussaint","year":"1997","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0022-3476(76)80260-0","article-title":"Diencephalic syndrome revisited","volume":"88","author":"Burr","year":"1976","journal-title":"J. Pediatr."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/0039-6257(94)90173-2","article-title":"Gliomas of the anterior visual pathway","volume":"38","author":"Dutton","year":"1994","journal-title":"Surv. Ophthalmol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/ana.410410204","article-title":"Optic pathway gliomas in children with neurofibromatosis 1: Consensus statement from the nf1 Optic Pathway Glioma Task Force","volume":"41","author":"Listernick","year":"1997","journal-title":"Ann. Neurol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1177\/08830738030180070401","article-title":"Optic pathway gliomas in children with and without neurofibromatosis","volume":"18","author":"Czyzyk","year":"2003","journal-title":"J. Child Neurol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"667","DOI":"10.2147\/CMAR.S362678","article-title":"Neurofibromatosis Type 1-Associated Optic Pathway Gliomas: Current Challenges and Future Prospects","volume":"15","author":"Tang","year":"2023","journal-title":"Cancer Manag. Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"212608","DOI":"10.7573\/dic.212608","article-title":"Neonatal pharmacology and clinical implications","volume":"8","author":"Ruggiero","year":"2019","journal-title":"Drugs Context"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1002\/cncr.22961","article-title":"Phase 2 study of temozolomide in children and adolescents with recurrent central nervous system tumors: A report from the Children\u2019s Oncology Group","volume":"110","author":"Nicholson","year":"2007","journal-title":"Cancer"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s11102-012-0401-0","article-title":"Childhood craniopharyngioma","volume":"16","year":"2013","journal-title":"Pituitary"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e2214","DOI":"10.1210\/clinem\/dgaa138","article-title":"Pretreatment endocrine disorders due to optic pathway gliomas in pediatric neurofibromatosis type 1: Multicenter study","volume":"105","author":"Santoro","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1365-2265.1980.tb01040.x","article-title":"Inappropriate growth hormone release in the diencephalic syndrome of childhood: Case report and 4 year endocrinological follow-up","volume":"13","author":"Drop","year":"1980","journal-title":"Clin. Endocrinol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s11060-013-1284-2","article-title":"Favorable survival and metabolic outcome for children with diencephalic syndrome using a radiation-sparing approach","volume":"116","author":"Kilday","year":"2013","journal-title":"J. Neuro-Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/0360-3016(94)00427-M","article-title":"Chronic neuroendocrinological sequelae of radiation therapy","volume":"31","author":"Sklar","year":"1995","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"6355","DOI":"10.1210\/jc.2005-1525","article-title":"Hypothalamic-pituitary dysfunction after irradiation of nonpituitary brain tumors in adults","volume":"90","author":"Agha","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_21","first-page":"1282","article-title":"Cranial irradiation and early puberty","volume":"78","author":"Shalet","year":"1994","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/S0360-3016(01)02788-2","article-title":"Radiation dose-volume effects on growth hormone secretion","volume":"52","author":"Goloubeva","year":"2002","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1093\/neuonc\/nos202","article-title":"Long-term follow-up of the multicenter, multidisciplinary treatment study HIT-LGG-1996 for low-grade glioma in children and adolescents of the German Speaking Society of Pediatric Oncology and Hematology","volume":"14","author":"Gnekow","year":"2012","journal-title":"Neuro-Oncology"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1210\/jc.2006-0322","article-title":"Diencephalic syndrome due to hypothalamic tumor: A model of the relationship between weight and puberty onset","volume":"91","author":"Brauner","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"WHO Multicentre Growth Reference Study Group (2006). WHO Child Growth Standards based on length\/height, weight and age. Acta Paediatr. Suppl., 450, 76\u201385.","DOI":"10.1111\/j.1651-2227.2006.tb02378.x"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e248","DOI":"10.1212\/WNL.0000000000003351","article-title":"Child Neurology: Diencephalic syndrome\u2013like presentation of a cervicomedullary brainstem tumor","volume":"87","author":"Conway","year":"2016","journal-title":"Neurology"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/ejhg.2009.125","article-title":"Septo-optic dysplasia","volume":"18","author":"Webb","year":"2010","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1210\/jcem-55-6-1167","article-title":"The effect of growth hormone treatment on somatomedin levels in a patient with dience-phalic syndrome","volume":"55","author":"Dean","year":"1982","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.23736\/S0375-9393.21.14825-4","article-title":"Metabolism and energy prescription in critically ill children","volume":"87","author":"Albert","year":"2021","journal-title":"Minerva Anestesiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1056\/NEJM197003192821209","article-title":"Starvation in man","volume":"282","author":"Sherwood","year":"1970","journal-title":"N. Engl. J. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1242\/dmm.026609","article-title":"Hypothalamic circuits regulating appetite and energy homeostasis: Pathways to obesity","volume":"10","author":"Timper","year":"2017","journal-title":"Dis. Model. Mech."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1056\/NEJMoa012908","article-title":"Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery","volume":"346","author":"Cummings","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1056\/NEJM197806082982306","article-title":"Fasting, feeding and regulation of the sympathetic nervous system","volume":"298","author":"Landsberg","year":"1978","journal-title":"N. Engl. J. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/nrc927","article-title":"Cachexia in cancer patients","volume":"2","author":"Tisdale","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/(SICI)1097-0142(19970701)80:1<142::AID-CNCR19>3.0.CO;2-Y","article-title":"Diencephalic syndrome and disseminated juvenile pilocytic astrocytomas of the hypothalamic-optic chiasm region","volume":"80","author":"Perilongo","year":"1997","journal-title":"Cancer"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1097\/00005072-199910000-00004","article-title":"Pediatric astrocytomas with monomorphous pilomyxoid features and a less favorable outcome","volume":"58","author":"Tihan","year":"1999","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s00401-016-1539-z","article-title":"Genetic alterations in uncommon low-grade neuroepithelial tumors: BRAF, FGFR1, and MYB mutations occur at high frequency and align with morphology","volume":"131","author":"Qaddoumi","year":"2016","journal-title":"Acta Neuropathol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1200\/JCO.2017.73.0242","article-title":"Pediatric gliomas: Current concepts on diagnosis, biology, and clinical management","volume":"35","author":"Sturm","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.2174\/0929867327666200806110206","article-title":"Diffuse Intrinsic Pontine Glioma (DIPG): Breakthrough and Clinical Perspective","volume":"28","author":"Perrone","year":"2021","journal-title":"Curr. Med. Chem."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 World Health Organization Classification of Tumors of the Central Nervous System: A summary","volume":"131","author":"Louis","year":"2016","journal-title":"Acta Neuropathol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/neuonc\/nox141","article-title":"Pediatric low-grade gliomas: Next biologically driven steps","volume":"20","author":"Jones","year":"2018","journal-title":"Neuro-Oncol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"8673","DOI":"10.1158\/0008-5472.CAN-08-2097","article-title":"Tandem duplication producing a novel oncogenic BRAF fusion gene defines the majority of pilocytic astrocytomas","volume":"68","author":"Jones","year":"2008","journal-title":"Cancer Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00401-011-0802-6","article-title":"Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma","volume":"121","author":"Schindler","year":"2011","journal-title":"Acta Neuropathol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/ng.2682","article-title":"Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma","volume":"45","author":"Jones","year":"2013","journal-title":"Nat. Genet."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S1470-2045(19)30277-3","article-title":"Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: A multicentre, phase 2 trial","volume":"20","author":"Fangusaro","year":"2019","journal-title":"Lancet Oncol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1056\/NEJMoa2303815","article-title":"Dabrafenib plus Trametinib in Pediatric Glioma with BRAF V600 Mutations","volume":"389","author":"Bouffet","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Talloa, D., Triarico, S., Agresti, P., Mastrangelo, S., Attin\u00e0, G., Romano, A., Maurizi, P., and Ruggiero, A. (2022). BRAF and MEK Targeted Therapies in Pediatric Central Nervous System Tumors. Cancers, 14.","DOI":"10.3390\/cancers14174264"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Zhang, M., Chen, T., and Zhong, Y. (2021). Demographic and prognostic factors of optic nerve astrocytoma: A retrospective study of surveillance, epidemiology, and end results (SEER). BMC Cancer, 21.","DOI":"10.1186\/s12885-021-08719-2"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/cge.14040","article-title":"Clinical variability of neurofibromatosis 1: A modifying role of cooccurring PTPN11 variants and atypical brain MRI findings","volume":"100","author":"Rosano","year":"2021","journal-title":"Clin. Genet."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/ana.21107","article-title":"Optic pathway gliomas in neurofibromatosis-1: Controversies and recommendations","volume":"61","author":"Listernick","year":"2007","journal-title":"Ann. Neurol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0022-3476(94)70122-9","article-title":"Natural history of optic pathway tumors in children with neurofibromatosis type 1: A longitudinal study","volume":"125","author":"Listernick","year":"1994","journal-title":"J. Pediatr."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/ajmg.a.20650","article-title":"Outcomes of systematic screening for optic pathway tumors in children with neurofibromatosis type 1","volume":"127A","author":"Blazo","year":"2004","journal-title":"Am. J. Med Genet. Part A"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1007\/s00381-013-2109-5","article-title":"Diencephalic syndrome as sign of tumor progression in a child with neurofibromatosis type 1 and optic pathway glioma: A case report","volume":"29","author":"Cavicchiolo","year":"2013","journal-title":"Child\u2019s Nerv. Syst."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1259\/bjr\/65246351","article-title":"Radiological classification of optic pathway gliomas: Experience of a modified functional classification system","volume":"81","author":"Taylor","year":"2008","journal-title":"Br. J. Radiol."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Lu, Y., Xu, M., Chen, X., Xu, H., Sun, N., Weisgerber, K.E., and Bai, R.-Y. (2025). Neurofibromatosis Type 1: Genetic Mechanisms and Advances in Therapeutic Innovation. Cancers, 17.","DOI":"10.3390\/cancers17233788"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"747","DOI":"10.3171\/jns.1997.86.5.0747","article-title":"Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas","volume":"86","author":"Packer","year":"1997","journal-title":"J. Neurosurg."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1007\/s10143-020-01357-5","article-title":"Spinal intramedullary schwannomas\u2014report of a case and extensive review of the literature","volume":"44","author":"Swiatek","year":"2021","journal-title":"Neurosurg. Rev."},{"key":"ref_58","first-page":"1","article-title":"Pilomyxoid astrocytoma: Diagnosis, prognosis, and management","volume":"18","author":"Komotar","year":"2005","journal-title":"Neurosurg. Focus"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1177\/19714009221083145","article-title":"Revisiting the use of proton magnetic resonance spectroscopy in distinguishing between primary and secondary malignant tumors of the central nervous system","volume":"35","author":"Farche","year":"2022","journal-title":"Neuroradiol. J."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1200\/JCO.2015.62.1383","article-title":"Comparing intelligence quotient change after treatment with proton versus photon radiation therapy for pediatric brain tumors","volume":"34","author":"Kahalley","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1001\/archneurpsyc.1958.02340060003001","article-title":"Gliomas of the optic nerves","volume":"79","author":"Dodge","year":"1958","journal-title":"AMA Arch. Neurol. Psychiatry"},{"key":"ref_62","unstructured":"Adam, M.P., Bick, S., Mirzaa, G.M., Pagon, R.A., Wallace, S.E., and Amemiya, A. (2025). Neurofibromatosis 1, University of Washington."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1002\/pbc.23006","article-title":"Impact of chemotherapy on disseminated low-grade glioma in children and adolescents: Report from the HIT-LGG 1996 trial","volume":"56","author":"Kortmann","year":"2011","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1200\/JCO.2016.68.1585","article-title":"Phase II weekly vinblastine for chemotherapy-na\u00efve children with progressive low-grade glioma: A Canadian Pediatric Brain Tumor Consortium study","volume":"34","author":"Lassaletta","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1002\/pbc.22748","article-title":"Optic pathway glioma: Long-term visual outcome in children without neurofibromatosis type-1","volume":"55","author":"Campagna","year":"2010","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1093\/neuonc\/nos076","article-title":"Visual outcomes in children with neurofibromatosis type 1-associated optic pathway glioma following chemotherapy: A multicenter retrospective analysis","volume":"14","author":"Fisher","year":"2012","journal-title":"Neuro-Oncol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1023\/A:1015853200090","article-title":"Hypersensitivity reactions to carboplatin in children","volume":"58","author":"Lazzareschi","year":"2002","journal-title":"J. Neuro-Oncol."},{"key":"ref_68","first-page":"750","article-title":"Pediatric low-grade gliomas: Implications of the biologic era","volume":"19","author":"Packer","year":"2017","journal-title":"Neuro-Oncol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1200\/JCO.2011.34.5843","article-title":"Phase II study of weekly vinblastine in recurrent or refractory pediatric low-grade glioma","volume":"30","author":"Bouffet","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1002\/cncr.21091","article-title":"Weekly vinblastine in pediatric low-grade glioma patients with carboplatin allergic reaction","volume":"103","author":"Holm","year":"2005","journal-title":"Cancer"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/pbc.24729","article-title":"Children <1 year show an inferior outcome when treated according to the traditional LGG treatment strategy: A report from the german multicenter trial HIT-LGG 1996 for children with low grade glioma (LGG)","volume":"61","author":"Mirow","year":"2014","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"7621","DOI":"10.1200\/JCO.2005.09.095","article-title":"Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: A report from the Children\u2019s Cancer Group","volume":"23","author":"Geyer","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Sofia, R., Melita, V., De Vita, A., Ruggiero, A., Romano, A., Attin\u00e0, G., Birritella, L., Lamendola, P., Lombardo, A., and Lanza, G.A. (2021). Cardiac Surveillance for Early Detection of Late Subclinical Cardiac Dysfunction in Childhood Cancer Survivors After Anthracycline Therapy. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.624057"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0360-3016(93)90342-S","article-title":"Optic glioma in children: Surveillance, resection, or irradiation?","volume":"25","author":"Jenkin","year":"1993","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1093\/jnci\/djp148","article-title":"Long-term outcomes among adult survivors of childhood central nervous system malignancies in the Childhood Cancer Survivor Study","volume":"101","author":"Armstrong","year":"2009","journal-title":"JNCI J. Natl. Cancer Inst."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/cncr.28387","article-title":"Second nonocular tumors among survivors of retinoblastoma treated with contemporary photon and proton radiotherapy","volume":"120","author":"Sethi","year":"2014","journal-title":"Cancer"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/00006123-200208000-00012","article-title":"Latency between symptom onset and diagnosis of pediatric brain tumors: An Eastern Canadian geographic study","volume":"51","author":"Mehta","year":"2002","journal-title":"Neurosurgery"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1093\/neuonc\/not120","article-title":"Detection of tumor progression in optic pathway glioma with and without neurofibromatosis type 1","volume":"15","author":"Kelly","year":"2013","journal-title":"Neuro-Oncol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1215\/15228517-2007-031","article-title":"Visual outcome of a cohort of children with neurofibromatosis type 1 and optic pathway glioma followed by a pediatric neuro-oncology program","volume":"9","author":"Via","year":"2007","journal-title":"Neuro-Oncol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1016\/S0140-6736(04)16413-1","article-title":"Growth hormone deficiency and related disorders: Insights into causation, diagnosis, and treatment","volume":"363","author":"Dattani","year":"2004","journal-title":"Lancet"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"3494","DOI":"10.1210\/jc.2006-0656","article-title":"Growth hormone treatment and risk of second neoplasms in the childhood cancer survivor","volume":"91","author":"Mertens","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1210\/jc.2011-0112","article-title":"Long-term safety of growth hormone replacement after CNS irradiation","volume":"96","author":"Mackenzie","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1056\/NEJMcp0800459","article-title":"Clinical practice. Precocious puberty","volume":"358","author":"Carel","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.1210\/jc.2007-0321","article-title":"Growth pattern and final height after cessation of gonadotropin-suppressive therapy in girls with central sexual precocity","volume":"92","author":"Lazar","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1210\/jc.2006-1374","article-title":"Turner Syndrome Study Group. Care of girls and women with Turner syndrome: A guideline of the Turner Syn-drome Study Group","volume":"92","author":"Bondy","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41572-021-00252-7","article-title":"Adrenal insufficiency","volume":"7","author":"Hahner","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1159\/000336333","article-title":"Diabetes insipidus\u2014Diagnosis and management","volume":"77","author":"Napoli","year":"2012","journal-title":"Horm. Res. Paediatr."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.beem.2016.02.007","article-title":"Diabetes insipidus: Differential diagnosis and management","volume":"30","author":"Robertson","year":"2016","journal-title":"Best Pr. Res. Clin. Endocrinol. Metab."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.metabol.2012.08.001","article-title":"Brain-derived neurotrophic factor and its relation to leptin in obese children before and after weight loss","volume":"62","author":"Roth","year":"2013","journal-title":"Metabolism"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"5395","DOI":"10.1210\/jc.2010-0993","article-title":"Reduced energy expenditure and impaired feeding-related signals but not high energy intake reinforces hypothalamic obesity in adults with childhood onset craniopharyngioma","volume":"95","author":"Holmer","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1210\/jc.2002-021180","article-title":"Risk factors for the development of obesity in children surviving brain tumors","volume":"88","author":"Lustig","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2165\/11531840-000000000-00000","article-title":"Hepatic veno-occlusive disease: A chemotherapy-related toxicity in children with ma-lignancies","volume":"12","author":"Cefalo","year":"2010","journal-title":"Paediatr. Drugs"},{"key":"ref_93","first-page":"569","article-title":"Safety and efficacy of fentanyl administered by patient controlled analgesia in children with cancer pain","volume":"15","author":"Ruggiero","year":"2007","journal-title":"Support. Care Cancer"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1086\/502454","article-title":"Candida parapsilosis bloodstream infection in pediatric oncology patients: Results of an epidemiologic investigation","volume":"25","author":"Posteraro","year":"2004","journal-title":"Infect. Control. Hosp. Epidemiol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"417949","DOI":"10.1155\/2011\/417949","article-title":"Hypothalamic obesity following craniopharyngioma surgery: Results of a pilot trial of combined diazoxide and metformin therapy","volume":"2011","author":"Hamilton","year":"2011","journal-title":"Int. J. Pediatr. Endocrinol."},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Romano, A., Triarico, S., Rinninella, E., Natale, L., Brizi, M.G., Cintoni, M., Raoul, P., Maurizi, P., Attin\u00e0, G., and Mastrangelo, S. (2022). Clinical Impact of Nutritional Status and Sarcopenia in Pediatric Patients with Bone and Soft Tissue Sarcomas: A Pilot Retrospective Study (SarcoPed). Nutrients, 14.","DOI":"10.3390\/nu14020383"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1080\/09593985.2022.2025966","article-title":"A survey of patient education practices and perceptions of physiotherapists: A mixed methods study","volume":"39","author":"Snook","year":"2023","journal-title":"Physiother. Theory Pract."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S1470-2045(04)01507-4","article-title":"Late neurocognitive sequelae in survivors of brain tumours in childhood","volume":"5","author":"Mulhern","year":"2004","journal-title":"Lancet Oncol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/mrdd.20110","article-title":"Neurocognitive effects of treatment for childhood cancer","volume":"12","author":"Butler","year":"2006","journal-title":"Ment. Retard. Dev. Disabil. Res. Rev."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1093\/neuonc\/nor015","article-title":"Early aging in adult survivors of childhood medulloblastoma: Long-term neurocognitive, functional, and physical outcomes","volume":"13","author":"Edelstein","year":"2011","journal-title":"Neuro-Oncol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1093\/jpepsy\/jsm045","article-title":"Acute neurocognitive response to methylphenidate among survivors of childhood cancer: A randomized, double-blind, cross-over trial","volume":"32","author":"Conklin","year":"2007","journal-title":"J. Pediatr. Psychol."},{"key":"ref_102","first-page":"1499","article-title":"Social competence in childhood brain tumor survivors: A comprehensive review","volume":"18","author":"Schulte","year":"2010","journal-title":"Support. Care Cancer"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1037\/a0016674","article-title":"Neurocognitive status in long-term survivors of childhood CNS malignancies: A report from the Childhood Cancer Survivor Study","volume":"23","author":"Ellenberg","year":"2009","journal-title":"Neuropsychology"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1200\/JCO.2005.01.158","article-title":"Serial evaluation of academic and behavioral outcome after treatment with cranial radiation in childhood","volume":"23","author":"Mabbott","year":"2005","journal-title":"J. Clin. Oncol."}],"container-title":["Children"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9067\/13\/2\/165\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T10:54:50Z","timestamp":1769424890000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9067\/13\/2\/165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,24]]},"references-count":104,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["children13020165"],"URL":"https:\/\/doi.org\/10.3390\/children13020165","relation":{},"ISSN":["2227-9067"],"issn-type":[{"value":"2227-9067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,24]]}}}